fda semaglutide news The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added The FDA has approved a

If youre still not sure about weight loss injections, we explain obesity, weight loss injections, and maintenance in this article to help you decide if weight loss injections in Franklin, TN, are right for you

In this article, well break down the latest evidence, side effect profiles, and long-term considerations to help you make an informed decision on GLP-1 therapy

For many patients, constipation improves within the first few weeks as the dose stabilizes and the body adapts

Choosing the right GLP-1 medication depends on your individual tolerance, health history, and how your body responds to different peptide pathways

Will an online GLP-1 provider accept your insurance